CAS 1853164-83-6

Formula: C24H27F3N8O3

InChI: InChI=1S/C24H27F3N8O3/c1-14-7-18(38-19-10-24(26,27)11-19)8-17(29-14)9-22(36)30-21-6-5-16(31-33-21)4-3-15(25)12-35-13-20(32-34-35)23(37)28-2/h5-8,13,15,19H,3-4,9-12H2,1-2H3,(H,28,37)(H,30,33,36)/t15-/m1/s1

InChI key: GEHZIZWHNLQFAS-OAHLLOKOSA-N

SMILES: CC1=CC(=CC(=N1)CC(=O)NC2=NN=C(C=C2)CC[C@H](CN3C=C(N=N3)C(=O)NC)F)OC4CC(C4)(F)F

IPN60090

CAS: 1853164-83-6

IPN60090

Formula: C₂₄H₂₇F₃N₈O₃

Purity: 99.5%

Molecular weight: 532.52

Ref: 54-BUP09340

(R)-1-(4-(6-(2-(4-(3,3-Difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

CAS: 1853164-83-6

Formula: C₂₄H₂₇F₃N₈O₃

Color and Shape: Solid

Molecular weight: 532.5182

Ref: IN-DA01N614

IPN-60090

CAS: 1853164-83-6

IPN-60090 is an analog of an anticancer kinase inhibitor that has shown promising results in the treatment of various types of cancer. It is a potent inhibitor of kinases that are involved in tumor cell proliferation and survival. IPN-60090 has been tested on Chinese hamster ovary cells and human urine-derived cancer cells, where it was found to induce apoptosis (programmed cell death) and inhibit the growth of cancer cells. This protein kinase inhibitor has shown excellent anticancer activity against a range of tumors, making it a promising candidate for the development of new cancer therapies. Additionally, IPN-60090 has been shown to have low toxicity and good safety profiles, making it an attractive option for further clinical development.

Formula: C₂₄H₂₇F₃N₈O₃

Purity: Min. 95%

Molecular weight: 532.5 g/mol

Ref: 3D-DZC16483

IPN60090

CAS: 1853164-83-6

IPN60090: potent oral GLS1 inhibitor, IC50 of 31 nM, potential for anticancer and immunomodulation.

Formula: C₂₄H₂₇F₃N₈O₃

Purity: 99.76%

Color and Shape: Solid

Molecular weight: 532.5182

Ref: TM-T11412